Morschhauser F, Feugier P, Flinn IW, et al. A phase 2 study of venetoclax plus R-CHOP as first-line treatment of patients with diffuse large B-cell lymphoma. Blood. 2021;137(5):600-609.

On page 600, in line 10 of the abstract, “research_plete” should read “complete.” On the same page, in “Introduction,” in lines 4 and 8 of the second column, “outresearch_e” should read “outcome.” The publisher apologizes for these composition errors, which have been corrected in the online version of the article.